Anti-LIN28 antibody [R03-8Y3] (STJA0036658)

SKU:
STJA0036658
€160.20 - €337.80
Processing The item has been added

Short Description :Rabbit monoclonal anti-LIN28 for use in WB, IHC-P, ICC, IF, IP and FC in Human samples. Datasheet included with dilution recommendations, and related reagents.
Applications:WB/IHC-P/ICC/IF/IP/FC
Host:Rabbit
Reactivity:Human
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :R03-8Y3
Isotype:IgG
Conjugation:Unconjugated
Purification:Affinity Chromatography
Dilution Range:WB 1:500-1:1000
IHC 1:50-1:100
IF 1:50-1:200
IP 1:50
FC 1:50-1:100
Formulation:Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage Instruction:Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.
Gene Symbol:LIN28A
LIN28B
Gene ID:79727
389421
Uniprot ID:LN28A_HUMAN
LN28B_HUMAN
Immunogen:A synthesized peptide derived from human LIN28
Tissue Specificity Q9H9Z2 - Expressed in embryonic stem cells, placenta and testis. Tends to be up-regulated in HER2-overexpressing breast tumors.
Q6ZN17 - Expressed at high levels in the placenta and, at mucher lower, in testis and fetal liver. Isoform 1 is only detected in placenta and in moderately and poorly differentiated hepatocellular carcinoma cells (at protein level). Isoform 2 is detected in fetal liver, non-tumor liver tissues, as well as well-differentiated tumor tissues (at protein level). Tends to be up-regulated in triple-negative (ER-,PR-,HER2-) breast tumors, as well as in liver, ovarian, and thyroid carcinomas.
Alternative Antibody Names Anti-Protein Lin-28 Homolog A antibody
Anti-Lin-28a antibody
Anti-Zinc Finger Cchc Domain-Containing Protein 1 antibody
Anti-LIN28A antibody
Anti-CSDD1 antibody
Anti-LIN28 antibody
Anti-ZCCHC1 antibody
Anti-Protein Lin-28 Homolog B antibody
Anti-Lin-28b antibody
Anti-LIN28B antibody
Anti-CSDD2 antibody

Information sourced from Uniprot.org